Lactate-induced anxiety after imipramine and diazepam treatment.

To examine the effect of treatment on lactate-induced anxiety in a controlled study, we infused 44 panic disorder patients with lactate and placebo before and after eight weeks of double-blind treatment with imipramine, diazepam, or placebo. During treatment, both imipramine and diazepam groups improved more than the placebo group. After treatment, patients in both the imipramine and diazepam groups had significantly less anxiety than the placebo patients when reinfused with lactate. In addition, imipramine decreased posttreatment panic attack frequency and diazepam decreased the perceived severity of posttreatment lactate-induced panic attacks. This study demonstrates that diazepam, like imipramine, is an effective treatment for panic disorder, and that both imipramine and diazepam blunt lactate-induced anxiety in a placebo controlled study.

[1]  G. Klerman,et al.  Drug Treatment of Panic Disorder: Comparative Efficacy of Alprazolam, Imipramine, and Placebo , 1992, British Journal of Psychiatry.

[2]  W. Agras,et al.  Imipramine and alprazolam effects on stress test reactivity in panic disorder , 1992, Biological Psychiatry.

[3]  P. Hauri,et al.  A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients. , 1991, Journal of clinical psychopharmacology.

[4]  S. Dager,et al.  Lactate vulnerability after alprazolam versus placebo treatment of panic disorder , 1991, Biological Psychiatry.

[5]  R. Noyes,et al.  Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. , 1991, The American journal of psychiatry.

[6]  J. Rosenbaum,et al.  Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. , 1991, The Journal of clinical psychiatry.

[7]  S. Targum Panic attack frequency and vulnerability to anxiogenic challenge studies , 1991, Psychiatry Research.

[8]  J. Rosenbaum,et al.  Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study. , 1990, The Journal of clinical psychiatry.

[9]  D. Greenblatt,et al.  Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. , 1990, Archives of general psychiatry.

[10]  R. Balon,et al.  Lactate-induced panic and beta-adrenergic blockade , 1990, Psychiatry Research.

[11]  W. Agras,et al.  Cardiovascular and Symptomatic Reduction Effects of Alprazolam and Imipramine in Patients with Panic Disorder: Results of a Double-Blind, Placebo-Controlled Trial , 1990, Journal of clinical psychopharmacology.

[12]  K. Rickels,et al.  Lorazepam vs. alprazolam in the treatment of panic disorder. , 1990, Pharmacopsychiatry.

[13]  G. Arana,et al.  The diagnostic utility of lactate sensitivity in panic disorder. , 1990, Archives of general psychiatry.

[14]  R. Glass,et al.  Response of panic disorder to fixed doses of alprazolam or imipramine. , 1989, Journal of affective disorders.

[15]  S. Woods,et al.  Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam. , 1989, The Journal of clinical psychiatry.

[16]  H. Westenberg,et al.  Behavioral biochemical and neuroendocrine concomitants of lactate-induced panic anxiety , 1989, Biological Psychiatry.

[17]  T. Aronson,et al.  Biological correlates of lactate sensitivity in panic disorder , 1989, Biological Psychiatry.

[18]  L. Rosenblum,et al.  Imipramine and alprazolam treatment of lactate-induced acute endogenous distress in nonhuman primates. , 1989, The American journal of psychiatry.

[19]  T. Aronson,et al.  Differential reactivity to lactate infusions: The relative role of biological, psychological, and conditioning variables , 1989, Biological Psychiatry.

[20]  Pyke Re,et al.  Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders. , 1989 .

[21]  D. Munjack,et al.  Alprazolam, Propranolol, and Placebo in the Treatment of Panic Disorder and Agoraphobia with Panic Attacks , 1989, Journal of clinical psychopharmacology.

[22]  G. Fava Fading of therapeutic effects of alprazolam in agoraphobia. Case reports , 1988, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[23]  R. Swinson,et al.  Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects. , 1988, Archives of general psychiatry.

[24]  A. Rifkin,et al.  Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. , 1988, Archives of general psychiatry.

[25]  R. Balon,et al.  Effects of laboratory-induced panic-anxiety on subsequent provocative infusions , 1988, Psychiatry Research.

[26]  R. Balon,et al.  Lactate- and isoproterenol-induced panic attacks in panic disorder patients and controls , 1988, Psychiatry Research.

[27]  J. Fulgham,et al.  Gravity feed administration of sodium lactate , 1987, Psychiatry Research.

[28]  E. Griez,et al.  Reduction of CO2-induced anxiety in patients with panic attacks after repeated CO2 exposure. , 1987, The American journal of psychiatry.

[29]  S. Dager,et al.  Biological markers in panic states: Lactate-induced panic and mitral valve prolapse , 1987, Biological Psychiatry.

[30]  J. Gorman,et al.  Discontinuation of alprazolam treatment in panic patients. , 1987, The American journal of psychiatry.

[31]  S. Woods,et al.  Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone. , 1986, The Journal of clinical psychiatry.

[32]  T. Uhde,et al.  Withdrawal syndrome with gradual tapering of alprazolam. , 1986, The American journal of psychiatry.

[33]  T. S. Hyde,et al.  Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study. , 1986, The Journal of clinical psychiatry.

[34]  W. Agras,et al.  Lactate infusions and panic attacks: Do patients and controls respond differently? , 1986, Psychiatry Research.

[35]  D. Greenblatt,et al.  Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy. , 1986, The American journal of psychiatry.

[36]  J. Gorman,et al.  Alprazolam in the treatment of panic disorders. , 1986, Journal of clinical psychopharmacology.

[37]  S. Siris,et al.  Panic disorder: Response to sodium lactate and treatment with antidepressants , 1985, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[38]  J. Gorman,et al.  Lactate vulnerability of remitted panic patients , 1985, Psychiatry Research.

[39]  James Jaccard,et al.  Pairwise multiple comparison procedures: A review. , 1984 .

[40]  J M Gorman,et al.  Lactate provocation of panic attacks. I. Clinical and behavioral findings. , 1984, Archives of general psychiatry.

[41]  J. Hinrichs,et al.  Diazepam and propranolol in panic disorder and agoraphobia. , 1984, Archives of general psychiatry.

[42]  R. Pohl,et al.  Tricyclic Antidepressants and Monoamine Oxidase Inhibitors in the Treatment of Agoraphobia , 1982, Journal of clinical psychopharmacology.

[43]  Paul A. Games,et al.  Simultaneous pairwise multiple comparison procedures for means when sample sizes are unequal. , 1981 .

[44]  D. Klein,et al.  Behavior therapy, supportive psychotherapy, imipramine, and phobias. , 1978, Archives of general psychiatry.

[45]  W. Rees,et al.  Lactate-Induced Anxiety: Therapeutic Application , 1971, British Journal of Psychiatry.

[46]  D. Kelly,et al.  Anxiety and the Effects of Sodium Lactate Assessed Clinically and Physiologically , 1971, British Journal of Psychiatry.

[47]  F. Pitts,et al.  Lactate metabolism in anxiety neurosis. , 1967, The New England journal of medicine.

[48]  M. Hamilton The assessment of anxiety states by rating. , 1959, The British journal of medical psychology.

[49]  K. Rickels,et al.  Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine. , 1993, Archives of general psychiatry.

[50]  K. Rickels,et al.  Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper. , 1993, Archives of general psychiatry.

[51]  E. Schweizer,et al.  The use of low-dose intranasal midazolam to treat panic disorder: a pilot study. , 1992, The Journal of clinical psychiatry.

[52]  F. Savoldi,et al.  Etizolam versus placebo in the treatment of panic disorder with agoraphobia: a double-blind study. , 1990, Current medical research and opinion.

[53]  S. Dager,et al.  Response to sodium lactate infusion in alcoholics with panic attacks. , 1989, The American journal of psychiatry.

[54]  F. Gaffney,et al.  Hemodynamic, ventilatory, and biochemical responses of panic patients and normal controls with sodium lactate infusion and spontaneous panic attacks. , 1988, Archives of general psychiatry.

[55]  I. Heuser,et al.  The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. , 1988, Journal of affective disorders.

[56]  J. Kinney,et al.  Ventilatory physiology of patients with panic disorder. , 1988, Archives of general psychiatry.

[57]  R. Rizley,et al.  A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder. , 1986, Psychopharmacology bulletin.

[58]  L. Covi,et al.  Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients. , 1986, Archives of general psychiatry.

[59]  W. Agras,et al.  Combined pharmacological and behavioral treatment for agoraphobia. , 1985, Behaviour research and therapy.

[60]  M. Rainey,et al.  The β-Receptor: Isoproterenol Anxiety States , 1984 .

[61]  D. Klein,et al.  Treatment of agoraphobia with group exposure in vivo and imipramine. , 1980, Archives of general psychiatry.

[62]  D. Sheehan,et al.  Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. , 1980, Archives of general psychiatry.

[63]  L. Covi,et al.  SCL-90: an outpatient psychiatric rating scale--preliminary report. , 1973, Psychopharmacology bulletin.

[64]  D F Klein,et al.  Importance of psychiatric diagnosis in prediction of clinical drug effects. , 1967, Archives of general psychiatry.